Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHIO Phio Pharmaceuticals

已收盘 04-30 16:00:00 EDT

1.92

-0.06

-3.03%

盘后2.02

+0.10+5.14%

19:57 EDT

最高2.04	最低1.82	成交量20.50万
今开1.95	昨收1.98	日振幅11.12%
总市值917.41万	流通市值916.49万	总股本477.82万
成交额38.88万	换手率4.30%	流通股本477.34万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":1.92,"timestamp":1746043200000,"preClose":1.98,"halted":0,"volume":205035,"hourTrading":{"tag":"盘后","latestPrice":2.0187,"preClose":1.92,"latestTime":"19:57 EDT","volume":28664,"amount":55096.9634,"timestamp":1746057460632},"delay":0,"floatShares":4773366,"shares":4778154,"eps":-9.079757,"marketStatus":"已收盘","change":-0.06,"latestTime":"04-30 16:00:00 EDT","open":1.95,"high":2.0352,"low":1.815,"amount":388784.332482,"amplitude":0.111212,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.079757,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746086400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.98,"preHourTrading":{"tag":"盘前","latestPrice":2.05,"preClose":1.98,"latestTime":"08:55 EDT","volume":2750,"amount":5576.47915,"timestamp":1746017701166},"postHourTrading":{"tag":"盘后","latestPrice":2.0187,"preClose":1.92,"latestTime":"19:57 EDT","volume":28664,"amount":55096.9634,"timestamp":1746057460632},"volumeRatio":0.396629,"impliedVol":2.2675,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PHIO","defaultTab":"news","newsList":[{"id":"2531726988","title":"Phio Pharmaceuticals Corp.4月29日成交额为48.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531726988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531726988?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:21","pubTimestamp":1745979703,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，Phio Pharmaceuticals Corp.成交额为48.72万美元，成交额较昨日增加7.64%，当日成交量为24.12万股。Phio Pharmaceuticals Corp.于2025年4月29日跌7.48%，报1.98美元，该股过去5个交易日跌21.12%，年初至今涨10.0%，过去60日跌3.88%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|48.72万|7.64%|24.12万|#|2025-04-28|45.27万|-51.84%|21.75万|#|2025-04-25|94.00万|-41.61%|44.50万|#|2025-04-24|160.98万|-22.49%|70.61万|#|2025-04-23|207.67万|3.45%|97.49万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102150a6ce28ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102150a6ce28ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2531214190","title":"Phio Pharmaceuticals Corp.4月28日成交额为45.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531214190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531214190?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:20","pubTimestamp":1745893217,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，Phio Pharmaceuticals Corp.成交额为45.27万美元，成交额较昨日减少51.84%，当日成交量为21.75万股。Phio Pharmaceuticals Corp.于2025年4月28日涨4.9%，报2.14美元，该股过去5个交易日跌24.38%，年初至今涨18.89%，过去60日跌3.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-28|45.27万|-51.84%|21.75万|#|2025-04-25|94.00万|-41.61%|44.50万|#|2025-04-24|160.98万|-22.49%|70.61万|#|2025-04-23|207.67万|3.45%|97.49万|#|2025-04-22|200.74万|12.49%|75.74万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429102025a6cc82ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429102025a6cc82ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2530151608","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530151608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530151608?lang=zh_cn&edition=full","pubTime":"2025-04-25 22:46","pubTimestamp":1745592410,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日22时46分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅跳水5.38%。截至发稿，该股报2.11美元/股，成交量15.4172万股，换手率3.23%，振幅6.73%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.34%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042522465194e2992a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042522465194e2992a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2530957943","title":"Phio Pharmaceuticals Corp.4月24日成交额为160.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530957943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530957943?lang=zh_cn&edition=full","pubTime":"2025-04-25 10:18","pubTimestamp":1745547527,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，Phio Pharmaceuticals Corp.成交额为160.98万美元，成交额较昨日减少22.49%，当日成交量为70.61万股。Phio Pharmaceuticals Corp.于2025年4月24日涨9.31%，报2.23美元，该股过去5个交易日跌17.41%，年初至今涨23.89%，过去60日跌12.55%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|160.98万|-22.49%|70.61万|#|2025-04-23|207.67万|3.45%|97.49万|#|2025-04-22|200.74万|12.49%|75.74万|#|2025-04-21|178.45万|-61.74%|66.15万|#|2025-04-17|466.43万|-32.93%|163.68万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101854a6c76891&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101854a6c76891&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2529986193","title":"Phio Pharmaceuticals Corp.4月21日成交额为178.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529986193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529986193?lang=zh_cn&edition=full","pubTime":"2025-04-22 10:19","pubTimestamp":1745288358,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日，Phio Pharmaceuticals Corp.成交额为178.45万美元，成交额较昨日减少61.74%，当日成交量为66.15万股。Phio Pharmaceuticals Corp.于2025年4月21日涨3.66%，报2.83美元，该股过去5个交易日涨62.64%，年初至今涨57.22%，过去60日涨20.94%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-21|178.45万|-61.74%|66.15万|#|2025-04-17|466.43万|-32.93%|163.68万|#|2025-04-16|695.40万|-44.29%|252.07万|#|2025-04-15|1248.27万|125.70%|459.79万|#|2025-04-14|553.07万|23.15%|274.68万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422101925a6c321da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422101925a6c321da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2528088600","title":"Phio Pharmaceuticals Corp.4月17日成交额为466.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528088600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528088600?lang=zh_cn&edition=full","pubTime":"2025-04-18 10:21","pubTimestamp":1744942888,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，Phio Pharmaceuticals Corp.成交额为466.43万美元，成交额较昨日减少32.93%，当日成交量为163.68万股。Phio Pharmaceuticals Corp.于2025年4月17日涨1.11%，报2.73美元，该股过去5个交易日涨65.45%，年初至今涨51.67%，过去60日涨19.21%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-17|466.43万|-32.93%|163.68万|#|2025-04-16|695.40万|-44.29%|252.07万|#|2025-04-15|1248.27万|125.70%|459.79万|#|2025-04-14|553.07万|23.15%|274.68万|#|2025-04-11|449.10万|-50.76%|255.22万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418102129a45d4db1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418102129a45d4db1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2527889212","title":"Phio Pharmaceuticals Corp.4月15日成交额为1248.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527889212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527889212?lang=zh_cn&edition=full","pubTime":"2025-04-16 10:14","pubTimestamp":1744769678,"startTime":"0","endTime":"0","summary":"美东时间2025年4月15日，Phio Pharmaceuticals Corp.成交额为1248.27万美元，成交额较昨日增加125.70%，当日成交量为459.79万股。Phio Pharmaceuticals Corp.于2025年4月15日涨10.45%，报2.43美元，该股过去5个交易日涨140.59%，年初至今涨35.0%，过去60日跌12.27%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-15|1248.27万|125.70%|459.79万|#|2025-04-14|553.07万|23.15%|274.68万|#|2025-04-11|449.10万|-50.76%|255.22万|#|2025-04-10|912.12万|-96.83%|576.39万|#|2025-04-09|2.88亿|227098.41%|1.51亿|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416101444a6bbf333&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416101444a6bbf333&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2527443546","title":"Phio Pharmaceuticals Corp.盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527443546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527443546?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:48","pubTimestamp":1744724902,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时48分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅上涨5.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Mural Oncology Plc、Verve Therapeutics, Inc.、Prokidney Corp.涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为578.38%、215.12%、85.43%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Nextcure, Inc.，振幅分别为80.08%、66.02%、38.78%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214822a6bb4fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214822a6bb4fcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2527044801","title":"Phio Pharmaceuticals Corp.4月14日成交额为553.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527044801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527044801?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:10","pubTimestamp":1744683050,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，Phio Pharmaceuticals Corp.成交额为553.07万美元，成交额较昨日增加23.15%，当日成交量为274.68万股。Phio Pharmaceuticals Corp.于2025年4月14日涨26.44%，报2.2美元，该股过去5个交易日涨113.59%，年初至今涨22.22%，过去60日跌24.4%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-14|553.07万|23.15%|274.68万|#|2025-04-11|449.10万|-50.76%|255.22万|#|2025-04-10|912.12万|-96.83%|576.39万|#|2025-04-09|2.88亿|227098.41%|1.51亿|#|2025-04-08|12.66万|49.69%|12.19万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415101058a6bab092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415101058a6bab092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2517016534","title":"Phio Pharmaceuticals Corp.盘中异动 大幅下挫5.04%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517016534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517016534?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:30","pubTimestamp":1741271425,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时30分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅下挫5.04%。截至发稿，该股报1.32美元/股，成交量2651股，换手率0.06%，振幅0.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.00%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223025abeb76f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223025abeb76f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2517941652","title":"Phio Pharmaceuticals Corp.盘中异动 急速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517941652?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:05","pubTimestamp":1741190746,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时05分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅上涨5.23%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.31%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306000546abe9cdfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306000546abe9cdfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2516608031","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速下挫5.30%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516608031?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:59","pubTimestamp":1741100396,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时59分，Phio Pharmaceuticals Corp.股票出现异动，股价快速下跌5.30%。截至发稿，该股报1.25美元/股，成交量3.962万股，换手率0.83%，振幅5.30%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.36%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225956a25f0d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225956a25f0d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2516681006","title":"Phio Pharmaceuticals Corp.盘中异动 下午盘股价大跌7.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516681006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516681006?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:19","pubTimestamp":1741033151,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时19分，Phio Pharmaceuticals Corp.股票出现异动，股价快速下跌7.75%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4599.47%、213.16%、183.18%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040419119637f9da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040419119637f9da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2514090074","title":"Phio Pharmaceuticals Corp.盘中异动 快速下挫6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090074?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:33","pubTimestamp":1740494014,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时33分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下挫6.01%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为759.92%、468.74%、242.26%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Dominari Holdings Inc.，振幅分别为20.51%、14.67%、11.73%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223334962ff2df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223334962ff2df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2513560773","title":"Phio Pharmaceuticals Corp.盘中异动 快速跳水5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513560773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513560773?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:37","pubTimestamp":1740411439,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时37分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下跌5.39%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为210.43%、89.48%、28.02%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242337209891056b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242337209891056b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2512911621","title":"Phio Pharmaceuticals Corp.盘中异动 快速下跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512911621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512911621?lang=zh_cn&edition=full","pubTime":"2025-02-19 04:25","pubTimestamp":1739910304,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日04时25分，Phio Pharmaceuticals Corp.股票出现波动，股价快速下跌5.52%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Aditxt, Inc.、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为912.66%、214.83%、173.12%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219042504a24af4eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219042504a24af4eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2511694823","title":"Phio Pharmaceuticals Corp.盘中异动 早盘大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511694823?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:23","pubTimestamp":1739546607,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时23分，Phio Pharmaceuticals Corp.股票出现波动，股价急速上涨5.03%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.11%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232327abcf127a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232327abcf127a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2510860846","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.77%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510860846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510860846?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:50","pubTimestamp":1739206214,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时50分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下跌5.77%。截至发稿，该股报1.78美元/股，成交量17.966万股，换手率3.76%，振幅5.82%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.09%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110050149880930e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110050149880930e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2509725908","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.91%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509725908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509725908?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:12","pubTimestamp":1738944756,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时12分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅跳水5.91%。截至发稿，该股报1.91美元/股，成交量9.5565万股，换手率2.00%，振幅6.16%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.29%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208001236987dbff0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208001236987dbff0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2509328004","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509328004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509328004?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:17","pubTimestamp":1738768664,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时17分，Phio Pharmaceuticals Corp.股票出现异动，股价快速下挫5.39%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3901.96%、1141.21%、671.41%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231744abc387e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231744abc387e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phiopharma.com","stockEarnings":[{"period":"1week","weight":-0.2112},{"period":"1month","weight":0.5349},{"period":"3month","weight":-0.1316},{"period":"6month","weight":-0.3356},{"period":"1year","weight":-0.6741},{"period":"ytd","weight":0.1}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phio Pharmaceuticals Corp.于2011年9月8日在特拉华州注册成立为Galena的全资子公司，以准备该公司计划从Galena分拆上市，该计划已于2012年4月27日完成。自该日起，该公司作为一家独立的上市公司运营。是一家生物技术公司，专注于发现、开发和商业化基于该公司专有的新一代RNA干扰（“RNAi”）平台的创新疗法。由于能够“沉默”或下调特定基因的表达，使用RNAi的治疗药物具有很大的前景。在2011年9月8日之前，该公司的业务作为Galena Biopharma，Inc.（“Galena”或“母公司”）内的非法人部门运营，该公司是该公司的前母公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.043516},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.058261},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.080913},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.067383},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.038426},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.020605},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.103097},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.030187},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.131629},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.131123},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.063336},{"month":12,"riseRate":0.181818,"avgChangeRate":-0.144776}],"exchange":"NASDAQ","name":"Phio Pharmaceuticals","nameEN":"Phio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phio Pharmaceuticals,PHIO,Phio Pharmaceuticals股票,Phio Pharmaceuticals股票老虎,Phio Pharmaceuticals股票老虎国际,Phio Pharmaceuticals行情,Phio Pharmaceuticals股票行情,Phio Pharmaceuticals股价,Phio Pharmaceuticals股市,Phio Pharmaceuticals股票价格,Phio Pharmaceuticals股票交易,Phio Pharmaceuticals股票购买,Phio Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}